Menu
Back to Journals » OncoTargets and Therapy » Volume 14
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum]
Authors LeVee A , Lin CY, Posadas E, Figlin R, Bhowmick NA, Di Vizio D, Ellis L , Rosser CJ, Freeman MR, Theodorescu D, Freedland SJ , Gong J
Received 12 October 2021
Accepted for publication 12 October 2021
Published 26 October 2021 Volume 2021:14 Pages 5167—5168
LeVee A, Lin CY, Posadas E, et al. Onco Targets Ther. 2021;14:4819–4832.
The authors have advised there is an error in the author list on page 4819. The author name “Charlos J Rosser” should read “Charles Joel Rosser”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.